ETOPOSIDE AND ACTINOMYCIN-D (EA) FOR METHOTREXATE (MTX) RESISTANT, LOW-RISK, PERSISTENT GESTATIONAL TROPHOBLASTIC DISEASE (GTD) AND EA WITHMTX (MEA) FOR HIGH-RISK GTD
Pc. Lorigan et al., ETOPOSIDE AND ACTINOMYCIN-D (EA) FOR METHOTREXATE (MTX) RESISTANT, LOW-RISK, PERSISTENT GESTATIONAL TROPHOBLASTIC DISEASE (GTD) AND EA WITHMTX (MEA) FOR HIGH-RISK GTD, European journal of cancer, 31A, 1995, pp. 1168-1168